Water → HCID 24781181, compound
Reaction equation
C(N(S(F)(F)[F:7])CC)C.[F:10][C:11]1[CH:12]=[C:13]([C@@H:19]2[CH2:28][C@@H:27](O)[CH2:26][C@@H:25]3[N:20]2[C:21](=[O:45])/[C:22](=[CH:30]/[C:31]2[CH:36]=[CH:35][C:34]([N:37]4[CH:41]=[C:40]([CH3:42])[N:39]=[CH:38]4)=[C:33]([O:43][CH3:44])[CH:32]=2)/[CH2:23][CH2:24]3)[CH:14]=[C:15]([F:18])[C:16]=1[F:17].O.C(OCC)(=O)C>ClCCl>[F:7][C@@H:27]1[CH2:26][C@@H:25]2[N:20]([C:21](=[O:45])/[C:22](=[CH:30]/[C:31]3[CH:36]=[CH:35][C:34]([N:37]4[CH:41]=[C:40]([CH3:42])[N:39]=[CH:38]4)=[C:33]([O:43][CH3:44])[CH:32]=3)/[CH2:23][CH2:24]2)[C@H:19]([C:13]2[CH:14]=[C:15]([F:18])[C:16]([F:17])=[C:11]([F:10])[CH:12]=2)[CH2:28]1.[CH3:44][O:43][C:33]1[CH:32]=[C:31]([CH:36]=[CH:35][C:34]=1[N:37]1[CH:41]=[C:40]([CH3:42])[N:39]=[CH:38]1)/[CH:30]=[C:22]1\[CH2:23][CH2:24][C@H:25]2[N:20]([C:21]\1=[O:45])[C@H:19]([C:13]1[CH:14]=[C:15]([F:18])[C:16]([F:17])=[C:11]([F:10])[CH:12]=1)[CH:28]=[CH:27][CH2:26]2.[CH3:44][O:43][C:33]1[CH:32]=[C:31]([CH:36]=[CH:35][C:34]=1[N:37]1[CH:41]=[C:40]([CH3:42])[N:39]=[CH:38]1)/[CH:30]=[C:22]1\[CH2:23][CH2:24][C@H:25]2[N:20]([C:21]\1=[O:45])[C@H:19]([C:13]1[CH:14]=[C:15]([F:18])[C:16]([F:17])=[C:11]([F:10])[CH:12]=1)[CH2:28][CH:27]=[CH:26]2Participants
Reactant 4
Product 3
Reagents, catalysts & solvents 1
Procedure
Diethylaminosulfur trifluoride (301 μL) was added to a solution of (E)-(6S,8S,9aR)-6-(3,4,5-trifluorophenyl)-8-hydroxy-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]octahydroquinolizin-4-one that is an optically active compound obtained above with a retention time of 4.4 minutes (228 mg) in dichloromethane (20 mL) under ice-cooling, and the reaction solution was stirred at room temperature overnight. Crushed ice, water, and ethyl acetate were added to the reaction solution, and the organic layer was separated. The resulting organic layer was washed with brine, dried over anhydrous magnesium sulfate, and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography (elution solvent: heptane-ethyl acetate system->ethyl acetate-methanol system) and CHIRALPAK™ AD-H manufactured by Daicel Chemical Industries, Ltd. (2 cm×25 cm; mobile phase: ethanol-hexane system) to obtain (E)-(6S,8R,9aR)-8-fluoro-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]-6-(3,4,5-trifluorophenyl)octahydroquinolizin-4-one (69 mg), (E)-(6S,9aR)-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]-6-(3,4,5-trifluorophenyl)-1,2,3,6,9,9a-hexahydroquinolizin-4-one (125 mg), and (E)-(6S,9aR)-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]-6-(3,4,5-trifluorophenyl)-1,2,3,6,7,9a-hexahydroquinolizin-4-one (1.8 mg). The property values of (E)-(6S,8R,9aR)-8-fluoro-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]-6-(3,4,5-trifluorophenyl)octahydroquinolizin-4-one are as follows.
Workup
- temperaturecooling
- customthe organic layer was separated
- washThe resulting organic layer was washed with brine
- dry with materialdried over anhydrous magnesium sulfate
- concentrationconcentrated under reduced pressure
- customThe residue was purified by silica gel column chromatography (elution solvent: heptane-ethyl acetate system->ethyl acetate-methanol system) and CHIRALPAK™ AD-H
Sources & evidence
- ORD record
- ord-b61f119fba634859a179934c58a96fc4
- Source dataset
- uspto-grants-2011_11
- Patent number
- US08048878B2
Reaction notes
Loading…